FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to developing and using a new pharmaceutical agent for optimizing the clinical course of reparative regeneration in skin burns. Disclosed is the use of peptide Thr-Gly-Glu-Asn-His-Arg-NH2 as a regulatory, protecting, normalizing and anti-inflammatory agent for treating burn skin lesions. Disclosed is a new composition of an anti-burn agent containing an active substance in the form of said regulatory peptide 0.1–100 mg/l, hydrogel based on Carbopol ETD 2020 4.5 g/l, and distilled water – the rest.
EFFECT: composition is highly effective in low doses of peptide Thr-Gly-Glu-Asn-His-Arg-NH2, convenient and easy to use.
2 cl, 4 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GEL-BASE FOR WOUND HEALING AND COSMETIC PREPARATION AND METHOD OF ITS OBTAINING | 2011 |
|
RU2485938C1 |
| PEPTIDE WITH NEUROPROTECTIVE ACTIVITY ON MODEL OF MFTP-INDUCED PARKINSONISM AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2017 |
|
RU2662429C1 |
| METHOD OF TREATING WOUNDS | 2019 |
|
RU2726599C1 |
| AGENT REDUCING RELATIVE CONTENT OF LOW-DIFFERENTIATED CELLS AND INCREASING RELATIVE CONTENT OF HIGH-DIFFERENTIATED CELLS IN INVASIVE MAMMARY GLAND CARCINOMA OF NON-SPECIFIC TYPE | 2022 |
|
RU2786528C1 |
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| METHOD FOR STOPPING EXTERNAL BLEEDING | 2018 |
|
RU2711570C1 |
| MEDICAL PRODUCT REDUCING CONTENT OF POORLY DIFFERENTIATED CELLS AND INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN NON-SPECIFIC INVASIVE BREAST CARCINOMA | 2019 |
|
RU2743710C1 |
| NOVEL ISOFORM OF TRYPSIN AND USE THEREOF | 2016 |
|
RU2814729C2 |
| NOVEL TRYPSIN ISOFORMS AND USE THEREOF | 2016 |
|
RU2739945C2 |
